Skip to content

The effect of Matricaria Chamomile extract on sleep quality in older adults

A clinical trial for determining of the effect of Matricaria Chamomile extract on sleep quality in older adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201609023618N5
Enrollment
60
Registered
2016-11-24
Start date
2016-04-18
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The effect of Matricaria Chamomile extract on sleep quality in older adults. G99.8* Other specified disorders of nervous system in diseases classified elsewhere

Interventions

Intervention 1: In the intervention group: Capsules containing 200 mg of Matricaria Chamomile extract, are prescribed twice daily (after lunch and dinner) for four weeks. Intervention 2: In the contro
Treatment - Drugs
In the intervention group: Capsules containing 200 mg of Matricaria Chamomile extract, are prescribed twice daily (after lunch and dinner) for four weeks.
In the control group: Capsules containing 200 mg wheat flour, are prescribed twice daily (after lunch and dinner) for four weeks.

Sponsors

University of Medical Science Kashan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age of 60 years and over; Obtaining a score of 5 or greater of the Pittsburgh Sleep Quality Index; Lack of a known mental illness; Lack of known allergies; Lack of continuous or sporadic use of Matricaria Chamomila or its products (as expressed by the patient); Being fully consciousness and ability to answer questions and give informed consent; Willingness to participate in the study and signing the informed consent; Not taking anticoagulant drugs (Heparin, Warfarin, Aspirin, Plavix); Lack of substance dependence and addiction (to drugs, alcohol, sedatives, antidepressants, hypnotics); Lack of known liver and kidney diseases or asthma, cancer, insulin-dependent diabetes, lupus, heart failure (based on the subjects’ health records). Exclusion criteria: Intolerance or reactions to Chamomile while studying; Chamomile withdrawal before the end of the intervention (at least for 3 days); A patient’s decision to withdraw from the study; Death; Hospitalization; Transfer to other centers.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sleep quality. Timepoint: Pre the intervention, two weeks after the intervention, four weeks after the intervention, six weeks after the intervention. Method of measurement: The score resulted from the Pittsburgh Sleep Quality Index.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyedeh Nessa Moussavi

Kashan University of Medical Sciences

Yasamin.Rastgar@yahoo.com+98 11 3322 4854

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026